Translate Bio, Inc. Contracts & Agreements

Second Amended and Restated Director Compensation Plan, adopted June 16, 2021 (Filed With SEC on August 5, 2021)

Letter Agreement, dated March 22, 2021, by and between the Registrant and Brendan Smith (Filed With SEC on August 5, 2021)

Consulting Agreement, dated June 16, 2021, by and between the Registrant and Daniel Lynch (Filed With SEC on August 5, 2021)

Agreement and Plan of Merger, dated as of August 2, 2021, by and among Sanofi, Vector Merger Sub, Inc. and Translate Bio, Inc (Filed With SEC on August 3, 2021)

First Amended and Restated Director Compensation Plan, adopted March 9, 2021 (Filed With SEC on May 6, 2021)

Letter Agreement, dated March 18, 2021, by and between the Registrant and E. Rand Sutherland (Filed With SEC on May 6, 2021)

Amended and Restated Employment Agreement, dated March 11, 2020, by and between Registrant and Ann Barbier (Filed With SEC on May 6, 2021)

Amended and Restated Employment Agreement, dated March 11, 2020, by and between Registrant and Paul Burgess (Filed With SEC on May 6, 2021)

2021 Inducement Stock Incentive Plan (Filed With SEC on March 1, 2021)

Form of Stock Option Agreement under the 2021 Inducement Stock Incentive Plan (No Acceleration) (Filed With SEC on March 1, 2021)

Form of Stock Option Agreement under the 2021 Inducement Stock Incentive Plan (Double Trigger Acceleration) (Filed With SEC on March 1, 2021)

Form of Stock Option Agreement under the 2021 Inducement Stock Incentive Plan (Single Trigger Acceleration) (Filed With SEC on March 1, 2021)

Indenture of Lease, dated November 3, 2020, by and between the Registrant and Boston Properties Limited Partnership (Filed With SEC on March 1, 2021)

Separation Agreement, dated December 27, 2020, by and between the Registrant and John R. Schroer (Filed With SEC on March 1, 2021)

First Amendment, dated September 22, 2020 to Suite Retention and Development Agreement, dated September 9, 2019, by and between Albany Molecular Research, Inc. and the Registrant (Filed With SEC on November 5, 2020)

Second Amendment to the Collaboration and License Agreement, dated June 22, 2020, by and between Translate Bio MA, Inc. and Sanofi Pasteur Inc (Filed With SEC on August 6, 2020)

Securities Purchase Agreement, dated June 22, 2020, by and between the Registrant and Sanofi, a French corporation (Filed With SEC on August 6, 2020)

Registration Rights Agreement, dated July 20, 2020, by and between the Registrant and Sanofi, a French corporation (Filed With SEC on August 6, 2020)

Supply Agreement, dated June 22, 2020, by and between Translate Bio MA Inc. and Sanofi Pasteur Inc (Filed With SEC on August 6, 2020)

Third Amendment to Exclusive Patent License Agreement, dated June 12, 2020, between the Massachusetts Institute of Technology and Shire AG, dated as of November 1, 2013, as amended (Filed With SEC on August 6, 2020)

Underwriting Agreement, dated June 25, 2020, by and among the Company, Goldman Sachs and Co. LLC, SVB Leerink LLC, Evercore Group L.L.C. and the selling stockholder of the Company... (Filed With SEC on June 26, 2020)

First Amendment to the Collaboration and License Agreement, dated March 26, 2020, by and between Translate Bio MA, Inc. and Sanofi Pasteur, Inc (Filed With SEC on May 7, 2020)

Description of Registrants Securities (Filed With SEC on March 12, 2020)

Amendment to Letter Agreement, dated March 11, 2020, by and between the Registrant and Ronald C. Renaud, Jr (Filed With SEC on March 12, 2020)

Amended and Restated Employment Agreement, dated March 11, 2020, by and between the Registrant and Brian Fenton (Filed With SEC on March 12, 2020)

Amended and Restated Employment Agreement, dated March 11, 2020, by and between the Registrant and John R. Schroer (Filed With SEC on March 12, 2020)

Amended and Restated Employment Agreement, dated March 11, 2020, by and between the Registrant and Richard Wooster (Filed With SEC on March 12, 2020)

Suite Retention and Development Agreement, dated September 9, 2019, by and between Albany Molecular Research Inc. and the Registrant (Filed With SEC on November 6, 2019)

Underwriting Agreement, dated September 17, 2019, by and among the Company and Citigroup Global Markets Inc., Jefferies LLC and SVB Leerink LLC (Filed With SEC on September 18, 2019)

Letter Agreement, dated August 6, 2015, as amended on October 18, 2017, by and between the Registrant and Brian Fenton (Filed With SEC on May 9, 2019)

Securities Purchase Agreement, dated April 30, 2019, by and among the Registrant and the other parties thereto (Filed With SEC on May 1, 2019)

Registration Rights Agreement, dated April 30, 2019, by and among the Registrant and the other parties thereto (Filed With SEC on May 1, 2019)

Form of Underwriting Agreement (Filed With SEC on June 12, 2018)

2018 Equity Incentive Plan (Filed With SEC on June 12, 2018)

Translate Bio, Inc. Director Compensation Policy (Filed With SEC on June 12, 2018)

Collaboration and License Agreement, dated June 8, 2018, by and between Translate Bio MA, Inc. and Sanofi Pasteur Inc (Filed With SEC on June 12, 2018)

First Amendment to Asset Purchase Agreement, by and between the Registrant and Shire Human Genetic Therapies, Inc., dated as of June 7, 2018 (Filed With SEC on June 12, 2018)

Asset Purchase Agreement, by and between the Registrant and Shire Human Genetic Therapies, Inc., dated as of December 22, 2016 (Filed With SEC on June 1, 2018)

Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on June 1, 2018)

Amended and Restated Registration Rights Agreement, by and among the Registrant and the other parties thereto, dated as of December 22, 2016 (Filed With SEC on June 1, 2018)

Exclusive Patent License Agreement between the Massachusetts Institute of Technology and Shire AG, dated as of November 1, 2013, as amended (Filed With SEC on June 1, 2018)

Form of Indemnification Agreement with directors and executive officers (Filed With SEC on June 1, 2018)

2016 Stock Incentive Plan, as amended (Filed With SEC on June 1, 2018)

Form of Incentive Stock Option Agreement under the 2016 Stock Incentive Plan (Filed With SEC on June 1, 2018)

Form of Nonstatutory Stock Option Agreement under the 2016 Stock Incentive Plan (Filed With SEC on June 1, 2018)

Form of Stock Option Agreement under the 2018 Equity Incentive Plan (Single Trigger Acceleration) (Filed With SEC on June 1, 2018)

Form of Stock Option Agreement under the 2018 Equity Incentive Plan (Double Trigger Acceleration) (Filed With SEC on June 1, 2018)

2018 Employee Stock Purchase Plan (Filed With SEC on June 1, 2018)

Letter Agreement, dated October 31, 2014, by and between the Registrant and Ronald C. Renaud, Jr (Filed With SEC on June 1, 2018)

Letter Agreement, dated August 5, 2016, by and between the Registrant and Thomas G. McCauley, Ph.D (Filed With SEC on June 1, 2018)

Letter Agreement, dated December 9, 2016, by and between the Registrant and Michael W. Heartlein, Ph.D (Filed With SEC on June 1, 2018)

Lease Agreement, dated June 29, 2017, by and between Translate Bio MA, Inc. and ARE-MA Region No. 8, LLC (Filed With SEC on June 1, 2018)

Consulting Agreement, dated June 1, 2012, as amended, by and between the Registrant and Daniel S. Lynch (Filed With SEC on June 1, 2018)

Consulting Agreement, dated July 1, 2016, by and between the Registrant and Owen Hughes (Filed With SEC on June 1, 2018)

Letter Agreement, dated April 19, 2018, as revised on April 23, 2018, by and between the Registrant and Thomas G. McCauley, Ph.D (Filed With SEC on June 1, 2018)

Letter Agreement, dated May 14, 2018, by and between the Registrant and John R. Schroer (Filed With SEC on June 1, 2018)

Category

Industry

Companies

Contracts

Translate Bio, Inc. Contracts & Agreements